Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Related Articles by Review for PubMed (Select 19226734)

1.
2.

Pneumonia in children in the developing world: new challenges, new solutions.

Schuchat A, Dowell SF.

Semin Pediatr Infect Dis. 2004 Jul;15(3):181-9. Review.

PMID:
15480964
3.

The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality.

Theodoratou E, Johnson S, Jhass A, Madhi SA, Clark A, Boschi-Pinto C, Bhopal S, Rudan I, Campbell H.

Int J Epidemiol. 2010 Apr;39 Suppl 1:i172-85. doi: 10.1093/ije/dyq033. Review.

4.

Progress towards meningitis prevention in the conjugate vaccines era.

Laval CA, Pimenta FC, de Andrade JG, Andrade SS, de Andrade AL.

Braz J Infect Dis. 2003 Oct;7(5):315-24. Review.

5.

Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002.

Watt JP, Levine OS, Santosham M.

J Pediatr. 2003 Dec;143(6 Suppl):S163-87. Review.

PMID:
14657805
6.

The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.

Gessner BD, Adegbola RA.

Vaccine. 2008 Jun 16;26 Suppl 2:B3-8. doi: 10.1016/j.vaccine.2008.04.013. Review.

PMID:
18793604
7.

Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions.

Levine OS, Knoll MD, Jones A, Walker DG, Risko N, Gilani Z.

Curr Opin Infect Dis. 2010 Jun;23(3):236-41. doi: 10.1097/QCO.0b013e328338c135. Review.

PMID:
20407316
8.
9.

The potential of pneumococcal conjugate vaccines to reduce antibiotic resistance.

Dagan R.

Adv Exp Med Biol. 2004;549:211-9. Review. No abstract available.

PMID:
15250535
10.

The preventable burden of pneumococcal disease in the developing world.

Scott JA.

Vaccine. 2007 Mar 22;25(13):2398-405. Epub 2006 Sep 18. Review.

PMID:
17028081
11.

The safety of 7-valent pneumococcal conjugate vaccine.

Ghaffar F.

Expert Opin Drug Saf. 2005 Jul;4(4):631-6. Review.

PMID:
16011442
12.

Vaccines against bacterial meningitis.

Segal S, Pollard AJ.

Br Med Bull. 2005 Mar 31;72:65-81. Print 2004. Review.

PMID:
15802609
13.

Community-acquired pneumonia in children.

McIntosh K.

N Engl J Med. 2002 Feb 7;346(6):429-37. Review. No abstract available.

PMID:
11832532
15.

Evaluation of vaccines for the prevention of pneumonia in children in developing countries.

Mulholland K, Levine O, Nohynek H, Greenwood BM.

Epidemiol Rev. 1999;21(1):43-55. Review.

16.

The potential indirect effect of conjugate pneumococcal vaccines.

O'Brien KL, Dagan R.

Vaccine. 2003 May 16;21(17-18):1815-25. Review.

PMID:
12706665
17.

Vaccine development for capsulate bacteria causing pneumonia.

Russell FM, Buttery J.

Curr Opin Pulm Med. 2003 May;9(3):227-32. Review.

PMID:
12682569
18.

Invasive pneumococcal disease and the need for the new 13-valent pneumococcal vaccine.

Bolton M, Barson W.

Pediatr Ann. 2010 Aug;39(8):497-503. doi: 10.3928/00904481-20100726-08. Review. No abstract available.

PMID:
20704146
19.

Bacterial meningitis: the impact of vaccination.

Makwana N, Riordan FA.

CNS Drugs. 2007;21(5):355-66. Review.

PMID:
17447825
20.

Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries.

Fitzwater SP, Watt JP, Levine OS, Santosham M.

Hum Vaccin. 2010 Oct;6(10):810-8. Epub 2010 Oct 1. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk